Deutsche Bank
GNCA

Deutsche Bank’s Genocea Biosciences, Inc. GNCA Stock Holding History

Deutsche Bank’s Portfolio GNCA Stock Details GNCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-10,324
Closed -$21K – 5183
2019
Q4 		$21K Buy
+10,324
New +$24.5K ﹤0.01% 4299
2019
Q2 		– Sell
-10,212
Closed -$48K – 5686
2019
Q1 		$48K Buy
+10,212
New +$50.5K ﹤0.01% 4571
2018
Q4 		– Sell
-288
Closed -$2K – 5608
2018
Q3 		$2K Sell
288
-6,903
-96% -$36.4K ﹤0.01% 5266
2018
Q2 		$50K Sell
7,191
-28,786
-80% -$215K ﹤0.01% 4783
2018
Q1 		$301K Buy
35,977
+27,335
+316% +$227K ﹤0.01% 3985
2017
Q4 		$79K Buy
8,642
+5,078
+142% +$51.1K ﹤0.01% 4320
2017
Q3 		$41K Sell
3,564
-545
-13% -$20.7K ﹤0.01% 4431
2017
Q2 		$170K Buy
4,109
+3,152
+329% +$152K ﹤0.01% 4013
2017
Q1 		$46K Buy
957
+167
+21% +$6.53K ﹤0.01% 4253
2016
Q4 		$26K Sell
790
-530
-40% -$17.5K ﹤0.01% 4533
2016
Q3 		$53K Sell
1,320
-2,878
-69% -$113K ﹤0.01% 4198
2016
Q2 		$137K Buy
4,198
+3,801
+957% +$139K ﹤0.01% 3957
2016
Q1 		$24K Sell
397
-272
-41% -$8.64K ﹤0.01% 4590
2015
Q4 		$27K Sell
669
-2,579
-79% -$123K ﹤0.01% 4662
2015
Q3 		$177K Sell
3,248
-4,850
-60% -$481K ﹤0.01% 3851
2015
Q2 		$889K Buy
+8,098
New +$752K ﹤0.01% 3045
2015
Q1 		– Sell
-608
Closed -$42.9K – 6240
2014
Q4 		$34K Buy
608
+45
+8% +$3.07K ﹤0.01% 5321
2014
Q3 		$40K Buy
563
+533
+1,777% +$58.4K ﹤0.01% 4958
2014
Q2 		$4K Sell
30
-138
-82% -$20.9K ﹤0.01% 5664
2014
Q1 		$24K Buy
+168
New +$20.6K ﹤0.01% 4788

Other funds holding GNCA

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Deutsche Bank's GNCA Position: Q1 2020 in Review

Deutsche Bank sold out of Genocea Biosciences, Inc. (GNCA) in Q1 2020, closing a stake of 10,324 shares — an estimated $21K sold.

Deutsche Bank first reported a position in GNCA in Q1 2014 and held it in 20 quarters. The position peaked at $889K in Q2 2015. 33 funds tracked by Wall St. Rank hold GNCA as of Q1 2020.

  • Deutsche Bank reported no remaining Genocea Biosciences, Inc. position as of Q1 2020 after selling out during the quarter.
  • Deutsche Bank sold 10,324 Genocea Biosciences, Inc. shares in Q1 2020, an estimated $21K.
  • Deutsche Bank first reported a position in Genocea Biosciences, Inc. in Q1 2014 and held it in 20 quarters.
  • Deutsche Bank's Genocea Biosciences, Inc. position peaked at $889K in Q2 2015.
  • 33 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q1 2020.

Based on Deutsche Bank's 13F filing for Q1 2020, filed 14 May 2020.